Login
$NRXS
$7.36 +$0.11 (1.52%) Close

Company Executives

$NRXS Management Team

Mr. Timothy Henrichs

Chief Financial Officer

Age 52
Compensation $638.5K USD
Sex Male

Dr. Adrian Miranda

Chief Medical Officer

Senior Vice President - Science and Technology

Age 55
Compensation $382.4K USD
Sex Male

Dr. Thomas Carrico

Chief Regulatory Officer

Compliance Officer and Privacy Officer

Age 68
Compensation $368.9K USD
Sex Male

Mr. Brian Carrico

President

Chief Executive Officer

Director

Age 43
Compensation $578.4K USD
Sex Male

Mr. Bradley Watkins

Independent Chairman of the Board

Age 50
Compensation $110.0K USD
Sex Male
Directors
5
serving now
Independent
3 of 3
stated in the proxy; 2 not stated
Average tenure
Not stated
from year joined
CEO also chairs the board
No
Bradley Mitch Watkins
Director Age On board Independent Committees Other public boards Pay Source
Brian Carrico
44 Not stated Not stated None stated None stated Paid as CEO
Christopher Robin Brown
72 Not stated Not stated None stated None stated Not stated
Bradley Mitch Watkins
51 Not stated Independent
Audit Committee Compensation Committee Nominating and Corporate Governance Committee
None stated Not stated
Beth Keyser
57 Not stated Independent
Audit Committee Compensation Committee Nominating and Corporate Governance Committee · Chair
None stated Not stated
Gilad Aharon
52 Not stated Independent
Compensation Committee · Chair
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

5 disclosed in the proxy filed Apr 28, 2026
two founding shareholders of the Company
founding shareholders
Amount not stated
as of December 31, 2025

Two demand notes receivable from the founding shareholders related to the sale of common stock; no payments received and balances fully reserved.

limited liability company in which the President and Chief Executive Officer and Chief Regulatory, Compliance and Privacy Officer hold an ownership interest
LLC in which the Company's President and Chief Executive Officer and Chief Regulatory, Compliance and Privacy Officer maintain an ownership interest
$4,412
year ended December 31, 2025

Exclusive license for the auricular portion of certain patents owned by the LLC; license costs incurred for patent maintenance.

With the Company Open in proxy
a member of the Company's Board of Directors
member of the Company's Board of Directors
$9,380
year ended December 31, 2025

Board member purchases NeuroStim devices at cost for research and development activities.

With the Company Open in proxy
the Company's former Chief Financial Officer
former Chief Financial Officer; managing partner and majority shareholder of the third-party public accounting firm
$44,365
year ended December 31, 2025

Accounting and tax services contracted on a continuous basis through a third-party public accounting firm.

With a third-party public accounting firm Open in proxy
the Company's former Chief Financial Officer
former Chief Financial Officer
$55,600
June 28, 2024

Issuance of 20,000 common shares with a fair value for services rendered during the IPO process.

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support